Related by context. Frequent words. (Click for all words.) 78 Patent Issued 77 Awarded Patent 77 Receives Patent 74 Files Patent 74 FDA Clears 73 Patent Covering 73 Achieves Milestone 73 Files Patent Infringement 72 Announces Immediate Availability 72 Completes Enrollment 71 Develop Next Generation 71 Develop Novel 71 Patent Lawsuit 70 Presents Positive 70 Receives FDA Clearance 70 Announces Issuance 70 Introduces Next Generation 70 Introduces Revolutionary 70 Releases Enhanced 69 Patent Infringement Lawsuit 69 Drug Candidate 69 Small Molecule 69 Launches Next Generation 69 Patient Enrollment 68 Provide Comprehensive 68 Announces Enhancements 68 Exclusive License 68 Q2 Loss Narrows 68 Clinical Trial Results 68 Introduces Enhanced 67 Preclinical Data 67 Announce Collaboration 67 Announces Initiation 67 FDA Accepts 67 Inc Therapeutic Competitors 67 Unveils Next Generation 67 Unveils Innovative 67 Announces Stockholder Approval 67 Signs Licensing Agreement 66 RNAi Therapeutics 66 Announces Additions 66 Files Shelf Registration Statement 66 Regains Compliance 66 Announce Availability 66 Patent Dispute 66 Provides Comprehensive 66 Reduces Risk 66 Named Cool Vendor 66 Announces Definitive Agreement 66 Secures Additional 66 FDA Clearance 66 Secures Financing 66 Q2 Loss Widens 66 AP PhotoExpress Network 66 Regains Compliance With 66 Patent Infringement Case 66 Secures Funding 66 Q3 Loss Narrows 66 Extends Leadership 66 Completes Tender Offer 66 Significantly Reduces 66 Exhibitor Profiles 66 Acquires Exclusive 66 Provides Guidance 66 Generic Version 65 Explore Strategic Alternatives 65 Receives Positive 65 Q1 Loss Narrows 65 Q1 Loss Widens 65 Report Analyzes 65 Q3 Loss Widens 65 Attains Gold Certified Partner 65 PRODUCT SOURCE 65 Shows Promise 64 Significantly Increases 64 Introduces Innovative 64 submitted Biologics License 64 Recombinant Human 64 Patent Infringement 64 Issues Guidance 64 Strengthens Its 64 Launches Unique 64 Exploit collaboration 64 Deliver Integrated 64 Complete Merger 64 Holds Promise 64 Transcept Pharmaceuticals 64 By PAMELA MCCLINTOCK 64 Commercialize 64 k Clearance 64 Acquire Assets 64 Reference Designs 64 Receives Notice 64 Further Strengthens 64 Unveils Latest 64 High Growth Forecasted 64 Deliver Enhanced 64 Phase III Clinical Trial 64 Provide Enhanced 63 Receives CE 63 Study Demonstrates